Suppr超能文献

加利福尼亚州扩大急诊科阿片类药物使用障碍治疗规模以减少过量死亡，2019-2023 年。

Scaling Emergency Department Opioid Use Disorder Treatment Across California to Reduce Overdose Deaths, 2019-2023.

机构信息

Elizabeth A. Samuels is with the Department of Emergency Medicine, Allison D. Rosen and Steve Shoptaw are with the Department of Family Medicine, and David Goodman-Meza is with the Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles. Melissa Speener, John Kaleekal, Serena Clayton, Arianna Campbell, and Andrew A. Herring are with CA Bridge, Public Health Institute, Oakland, CA. Mariah M. Kalmin is with the RAND Corporation, Santa Monica, CA. Chunqing Lin is with the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles. Aimee Moulin is with the Marshall Medical Center, Placerville, CA.

出版信息

Am J Public Health. 2024 Sep;114(9):874-878. doi: 10.2105/AJPH.2024.307710. Epub 2024 Jun 27.

DOI:10.2105/AJPH.2024.307710
PMID:38935888
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11306617/
Abstract

Since April 2019, CA Bridge has worked with emergency departments (EDs) in diverse geographic and emergency care settings across California to scale up low-threshold buprenorphine access, patient navigation programs, harm reduction services, and take-home naloxone. Between April 2019 and June 2023, 268 (81.0%) of 331 acute care hospitals in California received funding and technical assistance from CA Bridge and completed data reporting. These hospitals provided navigation services during 279 025 patient encounters and gave patients buprenorphine in 89 549 ED visits. (. 2024;114(9):874-878. https://doi.org/10.2105/AJPH.2024.307710).

摘要

自 2019 年 4 月以来，CA 大桥一直在加利福尼亚州不同地理位置和紧急护理环境的急诊部合作，以扩大低门槛丁丙诺啡的获取途径、患者导航计划、减少伤害服务，并提供纳洛酮带回家。在 2019 年 4 月至 2023 年 6 月期间，加利福尼亚州的 331 家急性护理医院中有 268 家（81.0%）获得了 CA 大桥的资金和技术援助，并完成了数据报告。这些医院在 279025 次患者就诊中提供了导航服务，并在 89549 次 ED 就诊中为患者提供了丁丙诺啡。（2024；114（9）：874-878。https://doi.org/10.2105/AJPH.2024.307710）。

相似文献

1
Scaling Emergency Department Opioid Use Disorder Treatment Across California to Reduce Overdose Deaths, 2019-2023.加利福尼亚州扩大急诊科阿片类药物使用障碍治疗规模以减少过量死亡，2019-2023 年。
Am J Public Health. 2024 Sep;114(9):874-878. doi: 10.2105/AJPH.2024.307710. Epub 2024 Jun 27.
2
Rapid Adoption of Low-Threshold Buprenorphine Treatment at California Emergency Departments Participating in the CA Bridge Program.加州参与 CA 桥梁项目的急诊部门快速采用低门槛丁丙诺啡治疗。
Ann Emerg Med. 2021 Dec;78(6):759-772. doi: 10.1016/j.annemergmed.2021.05.024. Epub 2021 Aug 2.
3
Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019.全州范围内的政策，增加在急诊就诊时提供纳洛酮以治疗阿片类药物过量，罗得岛州，2018-2019 年。
Am J Public Health. 2023 Apr;113(4):372-377. doi: 10.2105/AJPH.2022.307213. Epub 2023 Feb 6.
4
Evaluation of medications used for opioid use disorder in emergency departments: A cross-sectional analysis of the 2020 National Hospital Ambulatory Medical Care Survey.评估急诊科用于治疗阿片类药物使用障碍的药物：2020 年国家医院门诊医疗调查的横断面分析。
Am J Emerg Med. 2024 Aug;82:52-56. doi: 10.1016/j.ajem.2024.05.015. Epub 2024 May 20.
5
Naloxone and Buprenorphine Prescribing Following US Emergency Department Visits for Suspected Opioid Overdose: August 2019 to April 2021.纳洛酮和丁丙诺啡处方后，美国急诊疑似阿片类药物过量：2019 年 8 月至 2021 年 4 月。
Ann Emerg Med. 2022 Mar;79(3):225-236. doi: 10.1016/j.annemergmed.2021.10.005. Epub 2021 Nov 19.
6
Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.建模综合干预措施在避免合成阿片类药物过量流行期间死亡的影响。
Addiction. 2019 Sep;114(9):1602-1613. doi: 10.1111/add.14664. Epub 2019 Jun 28.
7
Identifying barriers to emergency department-initiated buprenorphine: A spatial analysis of treatment facility access in Michigan.识别急诊科启动丁丙诺啡治疗的障碍：密歇根州治疗机构可及性的空间分析。
Am J Emerg Med. 2022 Jan;51:393-396. doi: 10.1016/j.ajem.2021.11.014. Epub 2021 Nov 11.
8
Pharmacy harm reduction practices to help reduce opioid overdoses, Arizona 2023.2023年亚利桑那州帮助减少阿片类药物过量使用的药房减少伤害措施。
J Am Pharm Assoc (2003). 2025 May-Jun;65(3):102348. doi: 10.1016/j.japh.2025.102348. Epub 2025 Feb 12.
9
Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.为被认为有阿片类药物使用障碍高风险的急诊科患者提供纳洛酮。
Am J Emerg Med. 2021 Feb;40:173-176. doi: 10.1016/j.ajem.2020.10.061. Epub 2020 Nov 11.
10
Piloting a statewide emergency department take-home naloxone program: Improving the quality of care for patients at risk of opioid overdose.全州范围内急诊科纳洛酮带离项目试点：改善阿片类药物过量风险患者的护理质量。
Acad Emerg Med. 2022 Apr;29(4):442-455. doi: 10.1111/acem.14435. Epub 2022 Jan 28.

引用本文的文献

1
Emergency Clinician Buprenorphine Initiation, Subsequent Prescriptions, and Continuous Prescriptions.急诊临床医生启动丁丙诺啡治疗、后续处方及连续处方
JAMA. 2025 Apr 8;333(14):1232-1241. doi: 10.1001/jama.2024.27976.
2
Implementation of a peer-delivered opioid overdose response initiative in New York City emergency departments: Insight from multi-stakeholder qualitative interviews.在纽约市急诊科实施同伴提供的阿片类药物过量应对倡议：多利益相关方定性访谈的见解
J Subst Use Addict Treat. 2025 Jan;168:209542. doi: 10.1016/j.josat.2024.209542. Epub 2024 Oct 21.

本文引用的文献

1
Incidence of Precipitated Withdrawal During a Multisite Emergency Department-Initiated Buprenorphine Clinical Trial in the Era of Fentanyl.在芬太尼时代多中心急诊科启动的丁丙诺啡临床试验期间戒断反应诱发的发生率
JAMA Netw Open. 2023 Mar 1;6(3):e236108. doi: 10.1001/jamanetworkopen.2023.6108.
2
Effectiveness of Substance Use Navigation for Emergency Department Patients With Substance Use Disorders: An Implementation Study.物质使用导航对患有物质使用障碍的急诊科患者的有效性：一项实施研究。
Ann Emerg Med. 2023 Mar;81(3):297-308. doi: 10.1016/j.annemergmed.2022.09.025. Epub 2022 Nov 17.
3
Rapid Adoption of Low-Threshold Buprenorphine Treatment at California Emergency Departments Participating in the CA Bridge Program.加州参与 CA 桥梁项目的急诊部门快速采用低门槛丁丙诺啡治疗。
Ann Emerg Med. 2021 Dec;78(6):759-772. doi: 10.1016/j.annemergmed.2021.05.024. Epub 2021 Aug 2.
4
High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder.急诊科大剂量丁丙诺啡诱导治疗阿片类物质使用障碍
JAMA Netw Open. 2021 Jul 1;4(7):e2117128. doi: 10.1001/jamanetworkopen.2021.17128.
5
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis.阿片类激动剂治疗与阿片类药物依赖患者全因死亡率及特定死因的相关性：系统评价和荟萃分析。
JAMA Psychiatry. 2021 Sep 1;78(9):979-993. doi: 10.1001/jamapsychiatry.2021.0976.
6
Rhode Island's Opioid Overdose Hospital Standards and Emergency Department Naloxone Distribution, Behavioral Counseling, and Referral to Treatment.罗得岛州阿片类药物过量医院标准和急诊科纳洛酮分发、行为咨询以及转介治疗。
Ann Emerg Med. 2021 Jul;78(1):68-79. doi: 10.1016/j.annemergmed.2021.02.004. Epub 2021 Apr 15.
7
Participation in a Hospital Incentive Program for Follow-up Treatment for Opioid Use Disorder.参与医院激励计划以进行阿片类药物使用障碍的随访治疗。
JAMA Netw Open. 2020 Jan 3;3(1):e1918511. doi: 10.1001/jamanetworkopen.2019.18511.
8
Adoption and Utilization of an Emergency Department Naloxone Distribution and Peer Recovery Coach Consultation Program.采用并利用急诊纳洛酮分发和同伴康复教练咨询计划。
Acad Emerg Med. 2019 Feb;26(2):160-173. doi: 10.1111/acem.13545. Epub 2018 Oct 3.
9
Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses - United States, July 2016-September 2017.生命体征：2016年7月至2017年9月美国疑似阿片类药物过量急诊就诊趋势
MMWR Morb Mortal Wkly Rep. 2018 Mar 9;67(9):279-285. doi: 10.15585/mmwr.mm6709e1.
10
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.阿片类药物替代治疗期间及之后的死亡风险：队列研究的系统评价和荟萃分析
BMJ. 2017 Apr 26;357:j1550. doi: 10.1136/bmj.j1550.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验